Splunk Patent Case Vs An Ex-Employee's Growing Firm Has Merit, Analyst Says

  • Raymond James analyst Adam Tindle assigned Splunk Inc SPLK a Moderately Aggressive Risk/Wealth Accumulation (MA/ACC) rating given its fast-growing market
  • Splunk filed a lawsuit against Cribl, alleging infringement of numerous Splunk patents and unlawfully misappropriating Splunk's source code and other confidential materials
  • Cribl founder and CEO was previously a Splunk employee. Splunk states he founded Cribl on code stolen from Splunk. 
  • The analyst sees the nature of events as favorable to Splunk. 
  • Considering Splunk does not have a track record of taking legal action and has previously attempted to resolve allegations privately, he thinks the company must feel confident in its chances. 
  • Cribl's momentum may be a catalyst for the timing of this lawsuit, given ARR growth at 300% Y/Y in February and tripling its customer base, including 10 of the Fortune 50 (Splunk's core market). 
  • Splunk urged Cribl to stop using Splunk's IP and for fair compensation. 
  • The timing of a decision is unknown, with filing being the first step. With the size difference between the firms and Splunk's case indicating a positive outcome, he also cites an out-of-court settlement. 
  • UBS analyst Karl Keirstead downgraded Splunk to Neutral from Buy with a price target of $86, down from $125. 
  • The analyst's latest round of industry checks clarified the root cause of the company's recent $250 million annual recurring revenue guidance cut for 2023.
  • Also ReadBritish Chip Designer Arm Ropes In Splunk's Jason Child As Finance Chief
  • Price Action: SPLK shares traded lower by 5.23% at $78.95 on the last check Thursday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorNewsDowngradesPrice TargetReiterationAnalyst RatingsTechBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!